List of Vimachem Optimz Pharma Customers
Vimachem
18-31 42nd Street,
Astoria, 11105, NY,
United States
Astoria, 11105, NY,
United States
1 646-452-4411
Professional Services
60
$6M
Since 2010, our global team of researchers has been studying Vimachem Optimz Pharma customers around the world, aggregating massive amounts of data points that form the basis of our forecast assumptions and perhaps the rise and fall of certain vendors and their products on a quarterly basis.
Each quarter our research team identifies companies that have purchased Vimachem Optimz Pharma for Manufacturing Execution System from public (Press Releases, Customer References, Testimonials, Case Studies and Success Stories) and proprietary sources, including the customer size, industry, location, implementation status, partner involvement, LOB Key Stakeholders and related IT decision-makers contact details.
Companies using Vimachem Optimz Pharma for Manufacturing Execution System include: Aspen Pharmacare Australia, a Australia based Life Sciences organisation with 600 employees and revenues of $429.0 million, Elpen Pharmaceutical Co., a Greece based Life Sciences organisation with 816 employees and revenues of $112.0 million, Iberfar, a Portugal based Life Sciences organisation with 118 employees and revenues of $10.0 million and many others.
Contact us if you need a completed and verified list of companies using Vimachem Optimz Pharma, including the breakdown by industry (21 Verticals), Geography (Region, Country, State, City), Company Size (Revenue, Employees, Asset) and related IT Decision Makers, Key Stakeholders, business and technology executives responsible for the software purchases.
The Vimachem Optimz Pharma customer wins are being incorporated in our Enterprise Applications Buyer Insight and Technographics Customer Database which has over 100 data fields that detail company usage of software systems and their digital transformation initiatives. Apps Run The World wants to become your No. 1 technographic data source!
Apply Filters For Customers
| Logo | Customer | Industry | Empl. | Revenue | Country | Vendor | Application | Category | When | SI | Insight | Insight Source |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
 |
Aspen Pharmacare Australia | Life Sciences | 600 | $429M | Australia | Vimachem | Vimachem Optimz Pharma | Manufacturing Execution System | 2018 | n/a | In 2018 Aspen Pharmacare Australia deployed Vimachem Optimz Pharma and the Vimachem Serialization Site Manager Level 3 SSM as part of a Level 2 to 4 serialization architecture to meet EU FMD and other export-market requirements. Vimachem Optimz Pharma was provisioned in a Manufacturing Execution System role to provide site-level serialization control and GS1/EPCIS compliant event generation across export packaging operations. The implementation centered on the Serialization Site Manager Level 3 SSM, configured to capture serialization data, generate EPCIS events, and maintain product traceability at the case and pallet level. Configuration work focused on serialization workflows and eventing patterns consistent with Manufacturing Execution System responsibilities, aligning site execution with traceability and regulatory reporting requirements. Integration points included direct EPCIS feeds and an explicit integration with Tracelink at Level 4 to exchange serialized master data and event records, enabling export-market traceability across supply chain partners. Operational coverage extended from Aspen Australia manufacturing operations into multiple export markets, supporting manufacturing, quality, regulatory, and supply chain functions involved in serialized product release. Governance and rollout proceeded from the initial 2018 deployment through configuration refinement and integration testing, with the serialized system entering commercial introduction in July 2020. The program emphasized compliance with EU FMD and export-market serialization standards, maintaining GS1/EPCIS interoperability and site-level serialization governance. | |
 |
Elpen Pharmaceutical Co. | Life Sciences | 816 | $112M | Greece | Vimachem | Vimachem Optimz Pharma | Manufacturing Execution System | 2024 | n/a | In 2024, Elpen Pharmaceutical Co. implemented Vimachem Optimz Pharma to digitize packaging-line performance at its Pikermi manufacturing site. Vimachem Optimz Pharma is a Manufacturing Execution System and the initial deployment centered on the Manufacturing Analytics & OEE module. The implementation configured the Manufacturing Analytics & OEE module to capture shop floor events, perform OEE calculation, and surface real time dashboards and downtime analysis for packaging lines, leveraging Manufacturing Execution System workflows for data collection, KPI calculation, and operational visualization. Configuration work emphasized packaging-line event tagging, automated OEE computation, and configurable analytics views to support shift and line level decision making. Operational scope targeted manufacturing and operations teams at the Pikermi site with rollout activities focused on packaging lines and maintenance functions, and regional operations oversight for performance monitoring. The project aligned production engineering and operations management processes to standardize OEE reporting and root cause analysis workflows. According to the vendor case study, the deployment delivered rapid OEE improvements and achieved an ROI of 299 percent within months of deployment. Governance for the initiative embedded OEE metrics into routine operational review processes and established ongoing analytics cadence for continuous monitoring. | |
 |
Iberfar | Life Sciences | 118 | $10M | Portugal | Vimachem | Vimachem Optimz Pharma | Manufacturing Execution System | 2021 | n/a | In 2021, Iberfar implemented Vimachem Optimz Pharma as a Manufacturing Execution System to operationalize serialization and track and trace across its pharmaceutical manufacturing activities. The deployment targeted manufacturing and operations in the Europe region, aligning shop floor controls with global customer export requirements. The implementation explicitly included compliance handling for the Russian market. The implementation centered on Vimachem's Level 3 Serialization Site Manager SSM module, configured for real time shop floor serialization monitoring and vendor agnostic aggregation controls. Functional capabilities implemented included serialization event capture at packaging, aggregation reconciliation workflows, and monitoring dashboards for manufacturing operations. Configurations emphasized traceability at unit and batch levels consistent with Manufacturing Execution System practices. Integrations used vendor agnostic aggregation integration to interface with external packagers and downstream supply chain handlers, enabling exports and regulatory reporting workflows. The operational scope covered manufacturing, operations, and track and trace functions across Iberfar sites engaged in export activity within Europe. The solution was positioned to deliver real time serialization visibility and to support global customer serialization requirements and exports. The rollout was rapid, validated within two months, with site validation activities and serialization data governance established as part of the deployment. Governance changes included formalized aggregation reconciliation, shop floor monitoring procedures, and QA sign off gates to maintain serialization integrity. Vimachem Optimz Pharma now serves as Iberfar's Manufacturing Execution System for serialization and track and trace operations. |
Showing 1 to 3 of 3 entries
Buyer Intent: Companies Evaluating Vimachem Optimz Pharma
ARTW Buyer Intent uncovers actionable customer signals, identifying software buyers actively evaluating Vimachem Optimz Pharma. Gain ongoing access to real-time prospects and uncover hidden opportunities. Companies Actively Evaluating Vimachem Optimz Pharma for Manufacturing Execution System include:
- BioNTech, a Germany based Life Sciences organization with 3082 Employees
Discover Software Buyers actively Evaluating Enterprise Applications
| Logo | Company | Industry | Employees | Revenue | Country | Evaluated | ||
|---|---|---|---|---|---|---|---|---|
| No data found | ||||||||
FAQ - APPS RUN THE WORLD Vimachem Optimz Pharma Coverage
Vimachem Optimz Pharma is a Manufacturing Execution System solution from Vimachem.
Companies worldwide use Vimachem Optimz Pharma, from small firms to large enterprises across 21+ industries.
Organizations such as Aspen Pharmacare Australia, Elpen Pharmaceutical Co. and Iberfar are recorded users of
Vimachem Optimz Pharma for Manufacturing Execution System.
Companies using Vimachem Optimz Pharma are most concentrated in Life Sciences, with adoption spanning over 21 industries.
Companies using Vimachem Optimz Pharma are most concentrated in Australia, Greece and Portugal, with adoption tracked across 195 countries worldwide. This global distribution highlights the popularity of Vimachem Optimz Pharma across Americas, EMEA, and APAC.
Companies using Vimachem Optimz Pharma range from small businesses with 0-100 employees - 0%, to mid-sized firms with 101-1,000 employees - 100%, large organizations with 1,001-10,000 employees - 0%, and global enterprises with 10,000+ employees - 0%.
Customers of Vimachem Optimz Pharma include firms across all revenue levels — from $0-100M, to $101M-$1B, $1B-$10B, and $10B+ global corporations.
Contact APPS RUN THE WORLD to access the full verified Vimachem Optimz Pharma customer database with detailed Firmographics such as industry, geography, revenue, and employee breakdowns as well as key decision makers in charge of Manufacturing Execution System.